Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Scullin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
JAMA|February 13, 1978
Digitalis toxicity manifested by dysphagiaJ G Kelton, D C Scullin
American Journal of Hematology|January 1, 1979
Myelomatous pleural effusion: clinical course and immunologic characterization of the pleural fluid cellsD C Scullin, H J Cohen
The American Journal of Medicine|August 1, 1979
Pseudo-Gaucher cells in multiple myelomaD C Scullin, J D Shelburne, H J Cohen
The Journal of the Kentucky Medical Association|September 11, 1991
Splenectomy for hematologic disorders: a 20 year experienceR A Hoefer, D C Scullin, L F Silver, et al.
Cancer Investigation|June 19, 2001
Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research NetworkJ D Hainsworth, H A Burris, S W Calvert, et al.
Blood|June 1, 1980
Complement sensitivity of paroxysmal nocturnal hemoglobinuria bone marrow cellsJ Tumen, L B Kline, J W Fay, et al.
Blood|May 16, 2000
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphomaJ D Hainsworth, H A Burris, L H Morrissey, et al.
Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.
Cancer|April 3, 1999
Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinomaJ D Hainsworth, H A Burris, J B Erland, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
JAMA|February 13, 1978
Digitalis toxicity manifested by dysphagiaJ G Kelton, D C Scullin
American Journal of Hematology|January 1, 1979
Myelomatous pleural effusion: clinical course and immunologic characterization of the pleural fluid cellsD C Scullin, H J Cohen
The American Journal of Medicine|August 1, 1979
Pseudo-Gaucher cells in multiple myelomaD C Scullin, J D Shelburne, H J Cohen
The Journal of the Kentucky Medical Association|September 11, 1991
Splenectomy for hematologic disorders: a 20 year experienceR A Hoefer, D C Scullin, L F Silver, et al.
Cancer Investigation|June 19, 2001
Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research NetworkJ D Hainsworth, H A Burris, S W Calvert, et al.
Blood|June 1, 1980
Complement sensitivity of paroxysmal nocturnal hemoglobinuria bone marrow cellsJ Tumen, L B Kline, J W Fay, et al.
Blood|May 16, 2000
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphomaJ D Hainsworth, H A Burris, L H Morrissey, et al.
Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.
Cancer|April 3, 1999
Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinomaJ D Hainsworth, H A Burris, J B Erland, et al.
Pageof 1